Sensory neuron transient receptor potential vanilloid-1 channel regulates angiogenesis through CGRP in vivo

Sensory neuron transient receptor potential vanilloid-1 channel regulates angiogenesis through CGRP in vivo

Angiogenesis plays a key role in bone regeneration. The role of neurons of peripheral nerves involved in angiogenesis of bone defects needs to be explored. The transient receptor potential vanilloid 1 (TRPV1), a nociceptor of noxious stimuli, is expressed on sensory neurons. Apart from nociception,...

Full description

Bibliographic Details
Main Authors:	Zhanfeng Zhu, Yixuan Jiang, Zixia Li, Yu Du, Qinyi Chen, Qiang Guo, Yu Ban, Ping Gong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	transient receptor potential vanilloid 1 (TRPV1) calcitonin gene-related peptide (CGRP) angiogenesis vasculature bone defect
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2024.1338504/full

Similar Items

Lymphangiogenesis and angiogenesis rescue murine ischemic hindlimb via transient receptor potential vanilloid 4
by: Hideaki Yamada, et al.
Published: (2021-08-01)

Regulation of high-fat diet-induced microglial metabolism by transient receptor potential vanilloid type 1
by: SHA Xudong, et al.
Published: (2023-12-01)

The Vanilloid (Capsaicin) Receptor TRPV1 in Blood Pressure Regulation: A Novel Therapeutic Target in Hypertension?
by: Arpad Szallasi
Published: (2023-05-01)

Osteoporotic Pain is Associated with Increased Transient Receptor Vanilloid 4 Expression in the Dorsal Root Ganglia of Ovariectomized Osteoporotic Rats: A Pilot Basic Study
by: Sumihisa Orita, et al.
Published: (2018-07-01)

Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels
by: Johanna Kleeberg-Hartmann, et al.
Published: (2021-04-01)

CGRP: New Focus in Migraine
by: Necdet Karlı, et al.
Published: (2022-03-01)

Mode and site of action of therapies targeting CGRP signaling
by: Alejandro Labastida-Ramírez, et al.
Published: (2023-09-01)

Conserved allosteric pathways for activation of TRPV3 revealed through engineering vanilloid-sensitivity
by: Feng Zhang, et al.
Published: (2019-01-01)

Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
by: Vittorio Schweiger, et al.
Published: (2024-02-01)

Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer
by: Tomi Lois Adetunji, et al.
Published: (2022-07-01)

TRPV1: A Target for Rational Drug Design
by: Vincenzo Carnevale, et al.
Published: (2016-08-01)

Nutrition and Calcitonin Gene Related Peptide (CGRP) in Migraine
by: Michal Fila, et al.
Published: (2023-01-01)

The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
by: Birgit Vogler, et al.
Published: (2023-08-01)

Research trends in transient receptor potential vanilloid in cardiovascular disease: Bibliometric analysis and visualization
by: Lingfeng Zhang, et al.
Published: (2023-02-01)

Chronic Tear Deficiency Sensitizes Transient Receptor Potential Vanilloid 1-Mediated Responses in Corneal Sensory Nerves
by: Takayoshi Masuoka, et al.
Published: (2020-12-01)

Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord
by: Yukako Kamata, et al.
Published: (2020-06-01)

Transient Receptor Potential Cation Channel Subfamily Vanilloid 4 and 3 in the Inner Ear Protect Hearing in Mice
by: Shengnan Wang, et al.
Published: (2019-12-01)

Transient Receptor Potential Vanilloid 4-Dependent Microglial Function in Myelin Injury and Repair
by: Jameson P. Holloman, et al.
Published: (2023-12-01)

TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons
by: Wendy Wing Sze Yue, et al.
Published: (2022-08-01)

Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception—Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab
by: Nicola Benedicter, et al.
Published: (2024-03-01)

Research progress of transient potential receptor vanilloid 4 in ophthalmic diseases
by: Feng Wang, et al.
Published: (2023-01-01)

Sensitization and translocation of TRPV1 by insulin and IGF-I
by: Pauza Mary E, et al.
Published: (2005-04-01)

Molecular Surgery Concept from Bench to Bedside: A Focus on TRPV1+ Pain-Sensing Neurons
by: László Pecze, et al.
Published: (2017-06-01)

Advances in CGRP monoclonal antibodies as migraine therapy: A narrative review
by: Suruchi Aditya, et al.
Published: (2023-01-01)

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?
by: Theodoros Mavridis, et al.
Published: (2021-07-01)

A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel
by: Cesar A. Amaya-Rodriguez, et al.
Published: (2024-01-01)

Antinociceptive effects of dexmedetomidine via spinal substance P and CGRP
by: Li Ruiqin, et al.
Published: (2015-01-01)

The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
by: Mária Dux, et al.
Published: (2022-05-01)

Triptans and CGRP blockade – impact on the cranial vasculature
by: Silvia Benemei, et al.
Published: (2017-10-01)

Itch induced by peripheral mu opioid receptors is dependent on TRPV1-expressing neurons and alleviated by channel activation
by: Helvira Melo, et al.
Published: (2018-10-01)

TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis
by: Geoffrey Paltser, et al.
Published: (2013-05-01)

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
by: Valentina Favoni, et al.
Published: (2019-03-01)

CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
by: Manuela Rizzi, et al.
Published: (2022-09-01)

Effects of TRPA1 activation and inhibition on TRPA1 and CGRP expression in dorsal root ganglion neurons
by: Xiao-Lei Wang, et al.
Published: (2019-01-01)

Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells
by: Laura R. Sadofsky, et al.
Published: (2014-06-01)

Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system
by: Judit Rosta, et al.
Published: (2022-01-01)

Spinal Mobilization Prevents NGF-Induced Trunk Mechanical Hyperalgesia and Attenuates Expression of CGRP
by: William R. Reed, et al.
Published: (2020-04-01)

TRPV1 protects renal ischemia-reperfusion injury in diet-induced obese mice by enhancing CGRP release and increasing renal blood flow
by: Beihua Zhong, et al.
Published: (2019-02-01)

Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment
by: Philip V. Reducha, et al.
Published: (2023-02-01)

Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review
by: Dimitrios Rikos, et al.
Published: (2024-03-01)